We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.42B
AUM Growth
+$598M
Cap. Flow
+$113M
Cap. Flow %
2.08%
Top 10 Hldgs %
21.05%
Holding
659
New
99
Increased
247
Reduced
154
Closed
55

Top Buys

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$39.8M
2
TRIP icon
TripAdvisor
TRIP
+$35.2M
3
JPM icon
JPMorgan Chase
JPM
+$31.3M
4
LKQ icon
LKQ Corp
LKQ
+$30.8M
5
MKTX icon
MarketAxess Holdings
MKTX
+$28.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.36%
2 Financials 17.1%
3 Industrials 14.55%
4 Technology 11.07%
5 Healthcare 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
201
Netflix
NFLX
$292B
$1.35M 0.02%
256,900
-62,300
-20% -$306K
PETM
202
DELISTED
PETSMART INC
PETM
$1.34M 0.02%
18,450
-1,000
-5% -$73.2K
CMCSK
203
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$1.34M 0.02%
26,877
-228
-0.8% -$11.4K
COP icon
204
ConocoPhillips
COP
$147B
$1.33M 0.02%
18,852
-941
-5% -$67.6K
KMP
205
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$1.31M 0.02%
16,268
+636
+4% +$51.3K
FAST icon
206
Fastenal
FAST
$54B
$1.29M 0.02%
108,716
-4,352
-4% -$52.3K
WEC icon
207
WEC Energy
WEC
$37.7B
$1.28M 0.02%
31,078
PCYC
208
DELISTED
PHARMACYCLICS INC
PCYC
$1.27M 0.02%
12,057
-7,538
-38% -$915K
EFA icon
209
iShares MSCI EAFE ETF
EFA
$76.4B
$1.27M 0.02%
18,979
+195
+1% +$12.7K
AHT.PRD
210
Ashford Hospitality Trust Series D
AHT.PRD
$6.02M
$1.27M 0.02%
50,390
+15,500
+44% +$392K
YUM icon
211
Yum! Brands
YUM
$41B
$1.26M 0.02%
23,189
+1,793
+8% +$92.3K
ALGN icon
212
Align Technology
ALGN
$12B
$1.25M 0.02%
21,963
+753
+4% +$40.5K
BLK icon
213
Blackrock
BLK
$164B
$1.24M 0.02%
3,913
+210
+6% +$62.7K
MDLZ icon
214
Mondelez International
MDLZ
$77.7B
$1.23M 0.02%
34,962
+237
+0.7% +$7.88K
BMRN icon
215
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.22M 0.02%
17,390
-194,736
-92% -$13.2M
CVS icon
216
CVS Health
CVS
$137B
$1.2M 0.02%
16,802
+151
+0.9% +$9.7K
QQQ icon
217
Invesco QQQ Trust
QQQ
$455B
$1.2M 0.02%
13,639
+3,185
+30% +$265K
ABT icon
218
Abbott
ABT
$180B
$1.18M 0.02%
30,652
-516
-2% -$19K
MMM icon
219
3M
MMM
$89B
$1.17M 0.02%
9,952
+939
+10% +$100K
ITW icon
220
Illinois Tool Works
ITW
$81.4B
$1.16M 0.02%
13,822
+1,849
+15% +$146K
ENV
221
DELISTED
ENVESTNET, INC.
ENV
$1.14M 0.02%
28,264
+1,199
+4% +$43.7K
ABBV icon
222
AbbVie
ABBV
$458B
$1.13M 0.02%
21,416
+140
+0.7% +$6.88K
ASPS icon
223
Altisource Portfolio Solutions
ASPS
$65.4M
$1.12M 0.02%
+885
New +$1.07M
FIVE icon
224
Five Below
FIVE
$11.2B
$1.09M 0.02%
25,284
+2,054
+9% +$98.5K
VWO icon
225
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.09M 0.02%
26,516
-3,047
-10% -$126K

Similar funds

Geneva Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Geneva Advisors held 659 positions worth $5.42B, up 12% from $4.82B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q4 2013 filing shows 99 new, 247 increased, 154 reduced and 55 closed positions. Its largest new stake was LORILLARD INC COM STK: 798,445 shares worth $40.5M. The largest sale was RoadRunner Transportation Systems, Inc., an estimated $34.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2013 buy was LORILLARD INC COM STK: 798,445 shares worth $40.5M.
  • Geneva Advisors added most to JPMorgan Chase in Q4 2013, an estimated $31.3M increase.
  • Geneva Advisors's biggest Q4 2013 reduction was Chevron, cutting an estimated $33.8M.
  • Geneva Advisors fully exited RoadRunner Transportation Systems, Inc. in Q4 2013, selling an estimated $34.7M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.42B portfolio in Q4 2013.
  • Geneva Advisors opened 99 new positions and closed 55 in Q4 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $5.42B.

Based on Geneva Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.